Tevogen Bio Holdings Inc.
Support and Resistance Levels
Past performance
News About TVGN
All events for TVGN
All deals for TVGN
Financial Ratios
Financial Statements
TVGN vs Sector & Peers
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey. Website tevogen.com
Headquarters Warren, NJ, US